David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
CALL
Tucows
TCX
$101M
| $398K | ﹤0.01% |
+4,900
| New | +$357K |
|
3052
Winmark
WINA
$1.25B
| $397K | ﹤0.01% |
2,103
+24
| +1% | +$3.95K |
|
3053
Green Plains
GPRE
$1.03B
| $395K | ﹤0.01% |
+23,700
| New | +$355K |
|
3054
Novanta
NOVT
$5.28B
| $395K | ﹤0.01% |
4,659
-45,978
| -91% | -$3.45M |
|
3055
PUT
AngloGold Ashanti
AU
$62.4B
| $393K | ﹤0.01% |
30,000
-30,400
| -50% | -$409K |
|
3056
PUT
Brunswick
BC
$5.21B
| $393K | ﹤0.01% |
7,800
| – | – |
|
|
AL
3057
CALL
DELISTED
Air Lease Corp
AL
| $392K | ﹤0.01% |
+11,400
| New | +$411K |
|
3058
CALL
Cigna
CI
$73.8B
| $390K | ﹤0.01% |
2,424
| – | – |
|
3059
Dorian LPG
LPG
$2.17B
| $389K | ﹤0.01% |
60,574
-13,261
| -18% | -$77.7K |
|
3060
Atlanta Braves Holdings Series A
BATRA
$3.71B
| $388K | ﹤0.01% |
13,881
+451
| +3% | +$12.4K |
|
3061
First Merchants
FRME
$2.61B
| $388K | ﹤0.01% |
10,518
-28,014
| -73% | -$1.07M |
|
|
VIA
3062
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $386K | ﹤0.01% |
8,676
+4,769
| +122% | +$209K |
|
|
SIEN
3063
CALL
DELISTED
Sientra, Inc.
SIEN
| $386K | ﹤0.01% |
4,500
| – | – |
|
3064
Ameren
AEE
$29.6B
| $385K | ﹤0.01% |
5,231
-3,861
| -42% | -$269K |
|
3065
Exelon
EXC
$45.7B
| $384K | ﹤0.01% |
10,732
-5,188
| -33% | -$177K |
|
3066
PUT
FMC
FMC
$1.4B
| $384K | ﹤0.01% |
5,000
-765
| -13% | -$56.1K |
|
3067
Nordson
NDSN
$18.6B
| $384K | ﹤0.01% |
2,900
-9,435
| -76% | -$1.23M |
|
3068
CALL
Fluor
FLR
$6.86B
| $383K | ﹤0.01% |
+10,400
| New | +$380K |
|
3069
CALL
Omega Healthcare
OHI
$14.2B
| $382K | ﹤0.01% |
10,000
-45,100
| -82% | -$1.67M |
|
|
CRZO
3070
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $381K | ﹤0.01% |
+30,549
| New | +$363K |
|
3071
Q2 Holdings
QTWO
$3.98B
| $378K | ﹤0.01% |
5,459
-65,655
| -92% | -$4.1M |
|
|
CVA
3072
DELISTED
Covanta Holding Corporation
CVA
| $377K | ﹤0.01% |
21,792
-38,121
| -64% | -$623K |
|
|
BNY
3073
Bank of New York Mellon
BNY
$111B
| $376K | ﹤0.01% |
+7,460
| New | +$384K |
|
3074
Element Solutions
ESI
$8.65B
| $376K | ﹤0.01% |
37,259
-195,677
| -84% | -$2.17M |
|
3075
PUT
Essex Property Trust
ESS
$18.8B
| $376K | ﹤0.01% |
+1,300
| New | +$355K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.